Insurance - Life
Compare Stocks
2 / 10Stock Comparison
AAME vs MMC
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Brokers
AAME vs MMC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Insurance - Life | Insurance - Brokers |
| Market Cap | $51M | $85.27B |
| Revenue (TTM) | $208M | $26.45B |
| Net Income (TTM) | $5M | $4.13B |
| Gross Margin | 18.9% | 42.3% |
| Operating Margin | 3.2% | 23.2% |
| Forward P/E | — | 16.9x |
| Total Debt | $38M | $21.86B |
| Cash & Equiv. | $36M | $2.40B |
AAME vs MMC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Atlantic American C… (AAME) | 100 | 141.8 | +41.8% |
| Marsh & McLennan Co… (MMC) | 100 | 177.7 | +77.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AAME vs MMC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AAME is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.40, Low D/E 37.9%, current ratio 8.84x
- Better valuation composite
- +54.0% vs MMC's -21.6%
MMC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 19 yrs, beta 0.14, yield 1.8%
- Rev growth 7.6%, EPS growth 8.6%, 3Y rev CAGR 7.3%
- 210.8% 10Y total return vs AAME's -35.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.6% revenue growth vs AAME's 0.8% | |
| Value | Better valuation composite | |
| Quality / Margins | Combined ratio 0.8 vs AAME's 1.0 (lower = better underwriting) | |
| Stability / Safety | Beta 0.14 vs AAME's 0.40 | |
| Dividends | 1.8% yield, 19-year raise streak, vs AAME's 0.8% | |
| Momentum (1Y) | +54.0% vs MMC's -21.6% | |
| Efficiency (ROA) | 7.0% ROA vs AAME's 1.2%, ROIC 15.2% vs -3.6% |
AAME vs MMC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AAME vs MMC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
MMC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MMC is the larger business by revenue, generating $26.5B annually — 127.0x AAME's $208M. MMC is the more profitable business, keeping 15.6% of every revenue dollar as net income compared to AAME's 2.5%. On growth, AAME holds the edge at +20.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $208M | $26.5B |
| EBITDAEarnings before interest/tax | $7M | $7.0B |
| Net IncomeAfter-tax profit | $5M | $4.1B |
| Free Cash FlowCash after capex | $24M | $5.1B |
| Gross MarginGross profit ÷ Revenue | +18.9% | +42.3% |
| Operating MarginEBIT ÷ Revenue | +3.2% | +23.2% |
| Net MarginNet income ÷ Revenue | +2.5% | +15.6% |
| FCF MarginFCF ÷ Revenue | +11.6% | +19.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +20.8% | +11.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +127.1% | 0.0% |
Valuation Metrics
AAME leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $51M | $85.3B |
| Enterprise ValueMkt cap + debt − cash | $53M | $104.7B |
| Trailing P/EPrice ÷ TTM EPS | -10.91x | 21.28x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.89x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.11x |
| EV / EBITDAEnterprise value multiple | — | 15.96x |
| Price / SalesMarket cap ÷ Revenue | 0.27x | 3.49x |
| Price / BookPrice ÷ Book value/share | 0.51x | 6.38x |
| Price / FCFMarket cap ÷ FCF | 11.19x | 21.39x |
Profitability & Efficiency
MMC leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MMC delivers a 26.9% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $5 for AAME. AAME carries lower financial leverage with a 0.38x debt-to-equity ratio, signaling a more conservative balance sheet compared to MMC's 1.62x. On the Piotroski fundamental quality scale (0–9), MMC scores 6/9 vs AAME's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +4.9% | +26.9% |
| ROA (TTM)Return on assets | +1.2% | +7.0% |
| ROICReturn on invested capital | -3.6% | +15.2% |
| ROCEReturn on capital employed | -1.4% | +17.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.38x | 1.62x |
| Net DebtTotal debt minus cash | $2M | $19.5B |
| Cash & Equiv.Liquid assets | $36M | $2.4B |
| Total DebtShort + long-term debt | $38M | $21.9B |
| Interest CoverageEBIT ÷ Interest expense | 3.08x | 6.66x |
Total Returns (Dividends Reinvested)
Evenly matched — AAME and MMC each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MMC five years ago would be worth $13,665 today (with dividends reinvested), compared to $6,475 for AAME. Over the past 12 months, AAME leads with a +54.0% total return vs MMC's -21.6%. The 3-year compound annual growth rate (CAGR) favors AAME at 5.0% vs MMC's 0.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -12.8% | -3.6% |
| 1-Year ReturnPast 12 months | +54.0% | -21.6% |
| 3-Year ReturnCumulative with dividends | +15.8% | +2.0% |
| 5-Year ReturnCumulative with dividends | -35.3% | +36.6% |
| 10-Year ReturnCumulative with dividends | -35.0% | +210.8% |
| CAGR (3Y)Annualised 3-year return | +5.0% | +0.7% |
Risk & Volatility
MMC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MMC is the less volatile stock with a 0.14 beta — it tends to amplify market swings less than AAME's 0.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MMC currently trades 73.8% from its 52-week high vs AAME's 67.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.40x | 0.14x |
| 52-Week HighHighest price in past year | $3.71 | $235.78 |
| 52-Week LowLowest price in past year | $1.52 | $170.37 |
| % of 52W HighCurrent price vs 52-week peak | +67.7% | +73.8% |
| RSI (14)Momentum oscillator 0–100 | 49.3 | 37.2 |
| Avg Volume (50D)Average daily shares traded | 10K | 2.7M |
Analyst Outlook
MMC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
For income investors, MMC offers the higher dividend yield at 1.75% vs AAME's 0.80%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $206.75 |
| # AnalystsCovering analysts | — | 26 |
| Dividend YieldAnnual dividend ÷ price | +0.8% | +1.8% |
| Dividend StreakConsecutive years of raises | 1 | 19 |
| Dividend / ShareAnnual DPS | $0.02 | $3.05 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | +1.1% |
MMC leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AAME leads in 1 (Valuation Metrics). 1 tied.
AAME vs MMC: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is AAME or MMC a better buy right now?
For growth investors, Marsh & McLennan Companies, Inc.
(MMC) is the stronger pick with 7. 6% revenue growth year-over-year, versus 0. 8% for Atlantic American Corporation (AAME). Marsh & McLennan Companies, Inc. (MMC) offers the better valuation at 21. 3x trailing P/E (16. 9x forward), making it the more compelling value choice. Analysts rate Marsh & McLennan Companies, Inc. (MMC) a "Hold" — based on 26 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — AAME or MMC?
Over the past 5 years, Marsh & McLennan Companies, Inc.
(MMC) delivered a total return of +36. 6%, compared to -35. 3% for Atlantic American Corporation (AAME). Over 10 years, the gap is even starker: MMC returned +210. 8% versus AAME's -35. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — AAME or MMC?
By beta (market sensitivity over 5 years), Marsh & McLennan Companies, Inc.
(MMC) is the lower-risk stock at 0. 14β versus Atlantic American Corporation's 0. 40β — meaning AAME is approximately 190% more volatile than MMC relative to the S&P 500. On balance sheet safety, Atlantic American Corporation (AAME) carries a lower debt/equity ratio of 38% versus 162% for Marsh & McLennan Companies, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — AAME or MMC?
By revenue growth (latest reported year), Marsh & McLennan Companies, Inc.
(MMC) is pulling ahead at 7. 6% versus 0. 8% for Atlantic American Corporation (AAME). On earnings-per-share growth, the picture is similar: Marsh & McLennan Companies, Inc. grew EPS 8. 6% year-over-year, compared to -724. 4% for Atlantic American Corporation. Over a 3-year CAGR, MMC leads at 7. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — AAME or MMC?
Marsh & McLennan Companies, Inc.
(MMC) is the more profitable company, earning 16. 6% net margin versus -2. 3% for Atlantic American Corporation — meaning it keeps 16. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MMC leads at 23. 8% versus -2. 8% for AAME. At the gross margin level — before operating expenses — MMC leads at 42. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — AAME or MMC?
All stocks in this comparison pay dividends.
Marsh & McLennan Companies, Inc. (MMC) offers the highest yield at 1. 8%, versus 0. 8% for Atlantic American Corporation (AAME).
07Is AAME or MMC better for a retirement portfolio?
For long-horizon retirement investors, Marsh & McLennan Companies, Inc.
(MMC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 14), 1. 8% yield, +210. 8% 10Y return). Both have compounded well over 10 years (MMC: +210. 8%, AAME: -35. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between AAME and MMC?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
- Sector: Financial Services
- Market Cap > $100B
- Revenue Growth > 10%
- Dividend Yield > 0.5%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.